Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huanxiao Zhiqi Fang (缓哮止鼽方) is a Traditional Chinese Medicine (TCM) formula primarily used for the treatment of allergic rhinitis and potentially asthma. As a compound preparation, its therapeutic effects are understood through the holistic principles of TCM, which often involve balancing the body's internal systems. The formula is believed to work by addressing underlying imbalances in organs such as the lung, spleen, and kidney, and by dispelling external pathogenic factors like 'wind' that are thought to contribute to the symptoms of these conditions. It aims to strengthen the body's defensive qi (vital energy) and alleviate symptoms such as sneezing, nasal congestion, and runny nose. The exact composition of the formula can vary, as is common with traditional prescriptions, but it generally consists of a combination of various Chinese herbs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huanxiao Zhiqi Fang.